Q1 2023
Read transcript →Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ·Healthcare·Biotechnology
$3.51
+1.30%
Mkt Cap $207.43M
Q4 2022
Read transcript →Q3 2022
Read transcript →Q2 2022
Read transcript →Q1 2022
Read transcript →Q4 2021
Read transcript →Q3 2021
Read transcript →Q2 2021
Read transcript →Q1 2021
Read transcript →